Chemcrux Enterprises Q4 Results
- BSE: 540395
- NSE: CHEMCRUX
- ISIN: INE298W01016
- Sector: Biotechnology & Drugs
BSE
78.62
-1.02 (-1.28%)
-1.02 (-1.28%)Volume9.60 K
Updated: Tue 6 Oct, 2026 | 15:28:55
NSE
80.21
0.99 (1.25%)
0.99 (1.25%)Volume5.01 K
Updated: Tue 6 Oct, 2026 | 15:50:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Chemcrux Enterprises Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 21.27 | 19.77 | 7.57% |
| Depreciation/ Amortization | 1.17 | 1.19 | -1.10% |
| Operating Income | 3.01 | 2.34 | 28.58% |
| Net Income | 1.85 | 1.58 | 17.37% |
| Other Operating Expenses Total | 8.23 | 8.43 | -2.40% |
| Net Income Before Taxes | 2.67 | 2.19 | 22.19% |
| Total Revenue | 24.28 | 22.11 | 9.80% |
| Selling/ General/ Admin Expenses Total | 2.63 | 2.62 | 0.42% |
| Diluted Normalized EPS | 1.25 | 1.06 | 17.93% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.